Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$208 Mln
P/E Ratio
--
P/B Ratio
0.99
Industry P/E
--
Debt to Equity
0.06
ROE
-0.41 %
ROCE
-39.2 %
Div. Yield
0 %
Book Value
1.51
EPS
-0.71
CFO
$-314.69 Mln
EBITDA
$-410.57 Mln
Net Profit
$-398.36 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
QuantumSi Inc (QSI)
| -54.44 | -16.89 | -46.52 | -26.35 | -33.38 | -- | -- |
|
BSE Sensex
| 1.23 | 1.57 | 3.97 | 7.26 | 11.47 | 20.39 | 11.18 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
|
|---|---|---|---|
|
QuantumSi Inc (QSI)
| 34.01 | 9.84 | -76.75 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 37.43 | 10,135.98 | 20.78 | 23.13 | |
| 298.55 | 8,668.61 | 21.55 | 58.42 | |
| 27.22 | 9,559.25 | -- | -28.77 | |
| 106.73 | 10,030.35 | 30.81 | 14.16 |
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company offers Platinum NGPS instrument that provides single molecule amino... acid level resolution with a streamlined workflow, including automated data analysis that accessible to researchers in all laboratory types; Platinum Pro NGPS instrument, a single molecule amino acid resolution, which provides an enhanced user interface, cloud or on instrument data analysis and an available pro mode; Library preparation kits to prepare protein sample for sequencing; Barcoding Kits to optimize the workflow and performance of technology; and Sequencing Kits contains the reagents and consumables used to perform NGPS on the Platinum or Platinum Pro instrument. It also provides Platinum Analysis Software, a cloud-based solution that automates data analysis workflows and provides a user-friendly interface and visualization of the sequencing results. Its products are used in antibody characterization, biomarker identification, protein identification, protein variants, protein barcoding, and post translational modification analysis applications. Quantum-Si incorporated was founded in 2013 is headquartered in Branford, Connecticut. Address: 29 Business Park Drive, Branford, CT, United States, 06405 Read more
Founder & Executive Chairman
Dr. Jonathan M. Rothberg Ph.D.
Founder & Executive Chairman
Dr. Jonathan M. Rothberg Ph.D.
Headquarters
Branford, CT
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of QuantumSi Inc (QSI) stood at $ 248 Mln as on 31-Dec-24
The share price of QuantumSi Inc (QSI) is $1.23 (NASDAQ) as of 25-Apr-2025 16:23 EDT. QuantumSi Inc (QSI) has given a return of -33.38% in the last 3 years.
QuantumSi Inc (QSI) has a market capitalisation of $ 208 Mln as on 24-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of QuantumSi Inc (QSI) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the QuantumSi Inc (QSI) and enter the required number of quantities and click on buy to purchase the shares of QuantumSi Inc (QSI).
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company offers Platinum NGPS instrument that provides single molecule amino acid level resolution with a streamlined workflow, including automated data analysis that accessible to researchers in all laboratory types; Platinum Pro NGPS instrument, a single molecule amino acid resolution, which provides an enhanced user interface, cloud or on instrument data analysis and an available pro mode; Library preparation kits to prepare protein sample for sequencing; Barcoding Kits to optimize the workflow and performance of technology; and Sequencing Kits contains the reagents and consumables used to perform NGPS on the Platinum or Platinum Pro instrument. It also provides Platinum Analysis Software, a cloud-based solution that automates data analysis workflows and provides a user-friendly interface and visualization of the sequencing results. Its products are used in antibody characterization, biomarker identification, protein identification, protein variants, protein barcoding, and post translational modification analysis applications. Quantum-Si incorporated was founded in 2013 is headquartered in Branford, Connecticut. Address: 29 Business Park Drive, Branford, CT, United States, 06405
The CEO & director of Dr. Jonathan M. Rothberg Ph.D.. is QuantumSi Inc (QSI), and CFO & Sr. VP is Dr. Jonathan M. Rothberg Ph.D..
There is no promoter pledging in QuantumSi Inc (QSI).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,014
|
|
|
1,003
|
|
|
956
|
|
|
867
|
| QuantumSi Inc (QSI) | Ratios |
|---|---|
|
Return on equity(%)
|
-41.48
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
-3303.04
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of QuantumSi Inc (QSI) was $0 Mln.
$0.01
(
